Jean Francois Formela, Director at Intellia Therapeutics, Inc. (NTLA), sold 1,003,890 shares at $60.29 ($60.5M) on 2021-02-26, disclosed to the SEC on 2021-03-01.
Open-market sale of $60.5M NTLA by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $60.29 | 501,945 | $30.3M | 50.0% |
| 2 | $60.29 | 501,945 | $30.3M | 50.0% |
| Total | $60.29 avg | 1,003,890 | $60.5M | 100% |
| Filing → |
| KRRO | SELL | 2026-08-21 | $399K | — | Filing → |
| KRRO | SELL | 2026-08-13 | $30K | — | Filing → |
| KRRO | SELL | 2026-07-07 | $1.5M | — | Filing → |